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Abstract
Objective: Prostate cancer (PCA) is the most common malignancy and a major cause of death in
men but, importantly, a substantial proportion will live for several years following diagnosis.
However, they face the prospect of experiencing symptoms, side-effects of treatment and
diminished quality of life. The patient's psychological adjustment is particularly complex, given the
potential trajectory of the disease, from the point of diagnosis, with its immediate impact, to the
phase of palliative care, with its attendant issue of facing mortality. Since a comprehensive review
of the literature on psychological adjustment of men with PCA has not yet been done, we have
documented relevant research, integrated findings and drawn conclusions, where possible, in order
to map out clinical and research implications.
Method: We searched 5 databases for the period 1994 – July 2006, during which most of the work
in the field has been done.
Results: We found few studies of substance among the 60 we examined to draw conclusions about
psychological adjustment to prostate cancer and its treatment. This is in marked contrast to the
picture in breast cancer. While some patterns have emerged, many gaps remain to be filled.
Discussion: Aspects of methodology need attention, particularly longitudinal, prospective designs,
incorporation of control groups and the use of valid and reliable measures. There is scope for
qualitative studies as a complement to quantitative research.
Background
Prostate cancer (PCA) is the most common malignancy
and a major cause of death in men but, importantly, most
patients will live for a decade or longer following diagno-
sis. Consequently, they face the prospect of experiencing
symptoms, side-effects of treatment, and diminished
quality of life [1]. Research on psychological adjustment
to PCA suggests that it is related to factors such as the stage
of the cancer, time since diagnosis, and type of treatment
given. The latter is especially noteworthy, given the range
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tion treatment (external beam and brachytherapy), sur-
gery and hormonal therapy.
Puzzlingly, almost all research has been devoted to phys-
ical aspects and side-effects of treatment and very little to
such psychological features as emotional distress, coping
and psychiatric morbidity. Psychological adjustment is
complex, given the disease's potential trajectory – from
the point of diagnosis, with its immediate impact, to the
phase of palliative care, with its attendant existential
issues. Since a focused review of the literature on psycho-
logical adjustment has not yet been published, we have
documented what is known about this important aspect,
integrated pertinent findings and drawn conclusions,
where possible, in order to map out clinical and future
research implications.
In doing so, we extend the contribution of Eton and Lep-
ore [2], who reviewed studies on health-related quality of
life, both PCA-specific and general. They mainly paid
attention to physical aspects (urinary, sexual and bowel)
but psychosocial associations were also addressed. They
confined their coverage to three types of studies: cross-sec-
tional, longitudinal and those incorporating a compari-
son group. We have taken a different approach by
concentrating on psychological adjustment specifically
but refer when necessary to the physical domain. Kiss and
Meryn [3] have compared psychosocial aspects of PCA
and breast cancer but cited only a small proportion of the
studies published. Roesch et al. [4] have conducted a
meta-analytic review of coping with PCA, to which we
refer below.
Method
We searched five databases: Medline, PsycINFO, Biologi-
cal Abstracts, Sociological Abstracts and Cumulative Index
to Nursing and Allied Health (CINAHL), for the period
1994 – July 2006, during which period most of the
research had been done. Given the lack of a review on the
ways in which men with PCA deal with psychological
aspects of the experience, we opted to focus on the most
pertinent aspects of psychological and psychiatric mor-
bidity, coping and adjustment, and the potential effects of
psychosocial (interventions to assist patients to manage
effectively) used combinations of the following terms:
prostate cancer, psychological adjustment, psychiatric,
psychosocial, morbidity, distress, depression, anxiety,
coping, and quality of life (QOL). A manualized search of
relevant references cited in the identified articles followed.
Given the brief history of systematic research, we opted to
be inclusive but only incorporated studies with reasona-
bly sized and unbiased samples and appropriate designs,
including adequate descriptions of instruments used.
Thus, we have excluded, for instance, case histories and
anecdotal reports. We also omitted the small number of
non-English articles, research on couple and family
aspects (the subject of a separate review in press), and
studies that combined two or more cancer groups where it
was impossible to comment on the PCA subgroup sepa-
rately. We examined unpublished dissertations but did
not find any of notably original substance; it is conceiva-
ble that, if any of this work reaches peer-reviewed publica-
tion, it will then warrant attention of future reviewers.
We identified 60 reports, covering a range of topics. In
order to evaluate the material systematically, we parti-
tioned it into five coherent categories: cross-sectional, lon-
gitudinal, coping, PCA treatments and their psychological
effects and the impact of psychological interventions.
Given the constraints of space, we have created 8 tables
which contain the main elements of the studies we neces-
sarily have had to consider schematically in the text. After
addressing each in turn, we have concluded with a critique
of the overall endeavour and a discussion of clinical and
research implications. We had entertained conducting a
meta-analysis of intervention studies but concluded this
was unwarranted in that there were very few controlled tri-
als, and almost all of them were relatively unsophisticated
conceptually.
Cross-sectional studies of psychological adjustment to PCA 
(see Table 1)
Studies by Bacon et al. [5], Clark et al. [6] and Helgason et
al. [7] stand out since the samples are adequate and com-
pared with controls. The Helgason team reported dimin-
ished sexual function for both but that a greater
proportion of the men with PCA were 'severely distressed'
by this. Both Clark's and Bacon's groups found patients
more bothered than controls by bowel, urinary and sexual
symptoms, but mental health scores were similar in the
two groups in Bacon et al. In essence, although affected by
symptoms, patients did not report more distress than did
healthy men. Clark et al. found that psychological adjust-
ment was as affected as physical status. Questionnaires
developed for the latter study revealed greater complexity
than had previously been discerned. For example, certain
treatments were associated with patients' confidence that
the cancer was under control although they still felt a loss
of intimacy and masculinity.
Three papers have concentrated on depressive symptoms.
Heim and Oei [8] found one in five patients reporting
depression, half of these at the 'severe' level. Depression
correlated strongly with ratings of pain. The vaguely
described sample of convenience (80% labelled 'non-
metastatic') is a distinct limitation. Stone et al. [9]
observed severe levels of fatigue related to depression,
especially in men with advanced disease. Although the
study included controls, the sample was small, precludingPage 2 of 14
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assessed, retrospectively, 94 men at various stages of PCA.
Distress, as reflected in mixed depression and anxiety in
38% of them, was associated with poorer social, physical
and functional well-being. As this was a sample of patients
seeking support, it is difficult to generalise the findings.
Researchers have tended to view PCA patients as a homo-
geneous group but subgroups, for example men with
localised early-stage disease (often asymptomatic) and
metastatic disease (usually linked to recurrence), are iden-
tifiable. Different psychological reactions can be antici-
pated. Curran et al. [11], for instance, compared men with
localised, metastatic and hormone-resistant cancer. Those
with localised disease had better adjustment than the
advanced groups.
Patients with long-standing PCA grapple with several psy-
chological challenges. Schag et al. [12] studied this in a
convenience sample diagnosed five or more years earlier.
The men, particularly those with a co morbid physical or
psychiatric disorder, reported a decline in psychological
functioning, with escalating distress and cognitive impair-
ment.
McBride et al. [13] examined the psychological effects of a
cancer diagnosis using the Impact of Events Scale [14].
Strengths included the large sample of 420 men, most of
whom underwent surgery. A briefer period since diagnosis
and regular exercise were both related to lower levels of
psychological distress. Penedo et al. [15] examined the
relationship between perceived stress management skills,
optimism and positive mood in 46 men who had under-
gone radical prostatectomy for localised PCA. While opti-
mism was, not surprisingly, associated with positive
mood, the relationship was mediated by the self-reported
skills in stress management. The results support a focus on
promoting strategies to deal with stress in any psychoso-
cial intervention.
Few of the above investigations have enlisted large sam-
ples or controls, although we have noted three exceptions
Table 1: Cross-sectional studies of psychological adjustment to prostate cancer
Study Design Characteristics of the sample Major Findings
Bacon et al. (2002) • Retrospective comparison of patients and 
aged-matched healthy controls using the SF-
36, UCLA Prostate Cancer Index and the 
CARES-SF
• 783 men with PCA (localized disease), no 
breakdown by treatment; 1928 age-matched 
controls
• Patients had poorer sexual, urinary and 
bowel functioning but not role function or 
mental health
• Patients reported more bother from 
sexual, urinary and bowel functioning
• Symptoms were related to both physical 
and psychosocial QOL domains
Balderstone and Towell (2003) • Retrospective study of distress using 
FACT-P and the Hospital Anxiety & 
Depression Scale
• 94 men with PCA in various stages • Prevalence of distress: 38%
• Distress was related to poorer physical 
functioning and lower social support
Clark et al. (2003) • Retrospective comparison of patients and 
normal controls using the SF-12 and 
purpose-made symptom measures
• 349 men with early-stage PCA and 398 
controls
• Bowel, urinary and sexual symptoms 
created greater bother for men with PCA 
than for controls
• Bowel, then sexual, symptoms had greatest 
impact on QOL
Curran et al. (1997) • Baseline measures of QOL (EORTC-QLQ) 
in patients with advanced PCA
• 638 advanced-stage PCA patients in 1 of 3 
groups: Locoregional; Poor prognosis 
metastatic; Hormone resistant
• Four scales distinguished between the 3 
groups
• Locoregional group had better QOL than 
metastatic, or hormone resistant group
• Some physicians under-rated patients' level 
of pain
Heim and Oei (1993) • Retrospective study using the McGill Pain 
Questionnaire, Beck Depression Inventory, 
and State-Trait Anxiety Inventory
• 47 patients; 80% described as 'non-
metastatic'
• 43% reported pain; 20% reported 
depression
• Pain was correlated with depression and 
anxiety, increased use of analgesics, and later 
stages of disease
Helgason et al. (1996) • Retrospective observational study of PCA 
patients and age-matched controls' sexual, 
urinary and bowel functions using the 
Radiumhemmet Scale of Sexual Function
• 342 patients with mixed stage and 
treatment status, compared with 319 
controls of similar age
• Both groups experienced decline in sexual 
functioning but more PCA patients were 
severely distressed
• Urinary and bowel symptoms were less 
common and few were severely distressed 
as a result of them
McBride et al. (2000) • Cross-sectional study – mail-out to PCA 
and breast cancer patients using Impact of 
Events Scale and measures of lifestyle 
activities
• 920 (420 PCA; 93% radical prostatectomy. 
500 were breast cancer patients) usable 
responses from 1667 questionnaires 
distributed
• Breast cancer patients were younger, 
sicker and had higher trauma scores
• Trauma scores were negatively related to 
time from diagnosis
• Among the PCA patients, regular 
exercisers had lower trauma scores
Schag et al. (1994) • Retrospective observational study of QOL 
in cancer survivors using CARES
• 278 survivors (disease free); 57 lung, 117 
colon and 104 PCA
• QOL improved for colon cancer but 
decreased for PCA survivors
• All groups reported a range of QOL issues
Stone et al. (2000) • Retrospective comparison of fatigue and 
depression in cancer patients and healthy 
controls using EORTC-QLQ-30 and HADS
• 227 cancer patients, including 62 with 
PCA; 98 controls
• Fatigue is common in cancer, especially 
those with advanced disease
• Fatigue related to depression, anxiety, pain, 
dyspnoeaPage 3 of 14
(page number not for citation purposes)
BioPsychoSocial Medicine 2007, 1:2 http://www.bpsmedicine.com/content/1/1/2[5-7]. Nonetheless, we can state that PCA patients, exam-
ined at a single point, experience poor psychological
adjustment in relation to specific symptoms, particularly
sexual, bowel, pain and fatigue. They also exhibit psycho-
logical reactions not easily detected by broad measures.
The question as to whether associations are a function of
stage of disease, type of treatment or other factors remains
unanswered. Data comparing distress between clinical
subgroups are scanty [11].
Longitudinal studies of psychological adjustment to PCA 
(see Table 2)
The demands of a longitudinal design have presumably
militated against investigators tackling psychological
adjustment over time as such studies are rare. We have
identified a mere two, compared to the nine aforemen-
tioned cross-sectional studies. Nordin et al. [16] investi-
gated depression and anxiety over six months following
diagnosis. Levels of depression and anxiety at time of
diagnosis were lower in the PCA than other cancer groups
but were strong predictors of levels six months later, that
is, those initially depressed or anxious remained so at fol-
low up. Less social support outside the family and
advanced disease at baseline also predicted depression
and anxiety.
Visser et al. [17] examined QOL for three months follow-
ing a PCA diagnosis and compared them with those of
men diagnosed with benign prostatic hyperplasia (BPH).
Only the cancer patients experienced reduced QOL.
Importantly, the effect resulted from changed physical
functioning; psychological factors contributed only mar-
ginally.
Longitudinal designs allow researchers to track the course
of psychological adjustment but only one unreplicated
finding emerges from the scanty above work – levels of
depression and anxiety at the time of diagnosis identify
those likely to be feeling depressed or anxious at follow-
up. Screening and corresponding early intervention may
therefore reduce longer-term psychological ill-effects but
this ideal remains to be tested.
Patterns of coping (see Table 3)
We found a relatively small number of 'acceptable' papers
on coping, which is surprising given how relevant this
topic is for psychological adjustment. Roesch et al.,
(2005), in their meta-analysis, included a greater number
of studies, some of which did not meet our inclusion cri-
teria. Their conclusions were that active, as opposed to
more avoidant, approaches to coping with PCS are most
beneficial for adjustment. Our review of this topic sup-
ports these conclusions.
Helgeson and Lepore [18] investigated the role that self-
concept played in physical and emotional functioning.
Men who focused on themselves, compared to those more
interpersonally involved, had difficulty expressing emo-
tions, which in turn could have mediated adjustment to
their cancer.
The same group [19] examined men with PCA, diagnosed
an average 17 months earlier. Those who were psycholog-
ically distressed found it difficult to talk about their con-
dition with anyone. The authors speculated that support
networks might reduce distress by allowing men to "proc-
ess" their experience (a model familiar to those working
in the trauma area). While these results are of interest,
only prospective studies can illuminate the subject fur-
ther.
Zakowski et al. [20] have provided an intriguing analysis
of sex differences in emotional expression in cancer
patients. While the results are limited by sample size [41
women with breast cancer and 41 men with PCA) and
their inferences speculative, the findings warrant consid-
eration. Expected differences between the men and
women in terms of self-reported emotional expression as
a means of coping emerged but these were not significant.
However, the men reported that their spouses/partners
were likely to be their main source of support whereas
women had additional sources. Consequently, if men
reported constraints on emotional expression they were
likely to feel more distressed. Presumably, this was
because women had more opportunities to express them-
selves, a strategy promoting adjustment. The possibility,
that encouraging men's communication with their
Table 2: Longitudinal studies of psychological adjustment to prostate cancer
Study Design Characteristics of the sample Major Findings
Nordin et al. (2001) • 6 months study with 2 observation points 
Measures include the Hospital Anxiety & 
Depression Scale and the Impact of Events Scale
• 522 cancer patients (mixed diagnoses, 118 
with PCA, 8% late-stage PCA)
• Depression scores at diagnosis predicted 
levels 6 months later Risk factors: Advanced 
disease; low social support
• Recommendation: Screen with a depression 
measure and one social support question
Visser et al. (2003) • 3 months study with 2 observation points 
Measures include the EORTC
• 23 PCA and 38 benign prostate hyperplasia 
patients
• Large attrition rates
• Mixed therapy modes
• QOL for PCA patients decreased over the 3 
months but not for BPH patients
• Psychosocial factors were stable and 
contributed little to change in QOLPage 4 of 14
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promising one.
A common feature of coping research is to apply a stand-
ardised coping measure. A popular choice is the Mental
Adjustment to Cancer (MAC) scale [21]. Bjork et al. [22]
have used this, together with other measures, to investi-
gate adjustment of men with PCA. With a small sample,
and wide variation in the time between diagnosis and par-
ticipation, validity is in doubt; results, however, are worth
recounting. Helplessness was related to lowered self-
esteem, appraisal of loss to depression, appraisal of threat
to anxiety, and optimism, inversely, to depression and
anxiety.
Results from these, and from other studies we excluded
because of methodological limitations, have been inte-
grated in a comprehensive meta-analysis [4]. Approach-
type (problem-focused and emotion-focused) coping are
associated with more positive psychological adjustment
as well as better physical health in men with PCA. By con-
trast, avoidance-type strategies are linked to poor psycho-
logical adjustment and physical health. The evidence
supports encouraging approach-type coping in any poten-
tial intervention.
Despite drawing this implication, potential research limi-
tations must be borne in mind. Radically different ways of
conceptualising coping have been adopted, using retro-
spective, cross-sectional designs. Researchers need to
adopt a theory-based, prospective approach to study the
relationship between coping and adjustment if the con-
clusions by Roesch et al. are to be confirmed.
Treatments for PCA and psychological adjustment
Consensus has not been achieved as to indications of
treatments in PCA. Moreover, decision-making is influ-
enced by patients' attitudes to side-effects. As a corollary,
adjustment assumes greater relevance. If a treatment is
associated with side-effects such as fatigue and depres-
sion, overall psychological adjustment may deteriorate.
Research on links between treatment and adjustment is
clearly relevant. What follows is an account of this work,
starting with surgery.
Radical prostatectomy (RP) and psychological adjustment 
(see Table 4)
In the most impressive of seven studies found, involving
500 men [23], 70% completed questionnaires an average
three years after surgery (no measures were taken at base-
line). The mental health of those who did and did not
experience recurrence was compared. Mental health was
similar in the two groups, with overall satisfaction high.
Thus, regardless of recurrence, men seem well adjusted,
years after surgery.
In both an Italian survey of 161 men [21] and an Austral-
ian sample of 140 men [25], respondents mostly indi-
cated minimal adverse effects in adjustment. Overall
satisfaction was high. Sexual difficulties did not affect psy-
chological functioning, suggesting that pursuit of cure
outweighed sexual concerns.
British researchers [26], recognising that most erectile dys-
function questionnaires neglect psychological aspects,
developed and validated a 15-item questionnaire, the
Erectile Dysfunction Effect on QOL (ED-EQOL). They
demonstrated retrospectively that surgery had a negative
effect because of both direct physical factors and psycho-
logical influences. This study highlights the importance of
using probing questionnaires to uncover subtle effects,
rather than relying on diffuse survey tools.
Another Italian project [27] is less useful in that the sam-
ple was small. However, a control group undergoing sur-
gery for benign prostatic hyperplasia was included. The
PCA group had higher anxiety levels an average two years
after surgery.
Rondorf-Klym and Colling [29] examined psychological
adjustment 12 to 24 months after surgery. Perceived social
support, self-esteem and locus of control all contributed
to adjustment whereas age, sexual function and its
appraisal, suppression of anger and depression did not.
The above studies suffer from two main limitations – fol-
low-up ranging from one month to 15 years and psycho-
logical status, mostly assessed at a single point.
Adjustment after surgery is tantamount to a journey –
what patients encounter initially will differ from their
experience at later points. Studies of adjustment over time
are required, with distinctions made between immediate,
intermediate and long-term stages.
Radiotherapy (RT) and psychological adjustment (See 
Table 5)
The five identified reports are uninformative. Considering
the role of radiotherapy in PCA, this is surprising. An Ital-
ian study [30] is typical: 118 patients treated over a 13-
year period were invited to participate. Of these, 28
refused, and 20 were ineligible. The outcome measure was
ad hoc, comprising prostate-based items 'taken from dif-
ferent sources'. Follow-up ranged from months to years.
Thus, assessment occurred in the initial stage of therapy or
years later.
Given that brachytherapy (BT) is a recent development, its
association with psychological functioning has barely
been examined. French investigators [31] focused on the
association between combined BT and external beam RT,
and adjustment. In a rare design, controls were derivedPage 5 of 14
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the questionnaires at one point, four to eight years after
treatment. All scores were similar to those of controls, sug-
gesting that patients are not adversely affected by RT/BT
despite many experiencing loss of libido, decreased sexual
activity, erectile difficulty and urinary incontinence.
Only one study has concentrated on BT as a single treat-
ment modality [32]. In patients given a permanent
transperineal radioactive implant, only a minority was
psychologically impaired six months later. The pity is
omission of a baseline measure, longer follow-up and
controls. More work is needed on the psychological
impact of BT, an increasingly common treatment for
localised disease.
Two studies examined the association between RT and
fatigue. As is common in psychiatric samples, fatigue
could be due to depression. Monga et al. [33] examined
this question in men with localised cancer using a
repeated measures design. Fatigue did increase during RT
but this was not associated with depression changes. A
link however was found between fatigue and physical
well-being. In another investigation [34], the team sought
to determine the cause of fatigue and linked it to dimin-
ished neuromuscular efficiency, not psychological factors.
These studies of a prominent clinical feature like fatigue
are worthwhile, particularly the effort to tease out links
with psychological factors; useful psychological therapeu-
tic implications are likely to emerge.
Hormone therapy (HT) and psychological adjustment (see 
Table 6)
Suppressing androgens is an accepted intervention in met-
astatic PCA but its role in less advanced disease is clouded
given the complex issues involved – the goal of extending
survival, occurrence of side-effects and impact on the psy-
chological state.
The most noteworthy investigation of six identified is
Herr and O'Sullivan's [35] follow-up of men with locally
advanced PCA. While not a RCT, the men were offered
orchidectomy, pharmacological androgen suppression or
observation. Well-selected measures were administered at
baseline, and at six and 12 months. Men receiving HT
experienced significantly more distress than did those
under observation. The finding raises the question of how
to balance HT's adverse psychological effects with the
potential benefit of extended life.
Herr et al. [36] also compared QOL in HT-treated and
untreated men but on a sample diagnosed with metastatic
PCA. Again, men were offered HT or observation and fol-
lowed up for six months. The untreated group had better
psychological adjustment than the HT-treated.
A similar study involved patients treated with orchidec-
tomy or combined HT [37]. Measures covering fatigue
and emotional and social functioning were completed at
several points over 12 months. Although pain and urolog-
ical symptoms improved, emotional and social function-
ing did not. This study stands out methodologically by
Table 3: Coping in men with prostate cancer
Study Design Characteristics of the sample Major Findings
Bjork et al. (1999) • Cross-sectional study – mail-out survey 
using the Mental Adjustment to Cancer Scale, 
The Life Orientation Test, Beck Depression 
Inventory and the Stait-Trait Anxiety 
Inventory
• 30 usable responses (mean 62 years since 
diagnosis) from 55 questionnaires distributed
• Completed a range of distress-related and 
self-esteem measures
• Helplessness related to lower self-esteem; 
Loss appraisals to depression; threat 
appraisals to anxiety; optimism negatively 
related to depression and anxiety
Helgeson and Lepore (1997) • Cross-sectional study – mail-out using the 
CARES and several measures developed for 
the study
• 162 usable responses from 258 
questionnaires distributed Most (83%) were 
radical prostatectomies, a mean of 13 months 
since diagnosis
• Self-focused identity associated with worse 
functioning, greater cancer difficulties and 
poorer emotional expression
• Expressed emotion mediated the links 
between self-identity and cancer difficulties
Lepore and Helgeson (1998) • Cross-sectional study – mail-out using MHI-
5, Impact of Events Scale, and CARES
• 181 usable responses from 258 
questionnaires distributed Most (83%) were 
radical prostatectomies, a mean of 13 months 
since diagnosis
• Social constraints in talking about cancer 
moderated trauma and mental health 
relationships
• Conclusion: Supportive social networks 
may promote psychological adjustment by 
facilitating cognitive processing of the cancer 
experience
Penedo et al. (2003) • Cross-sectional study using the Life 
Orientation Test-Revised and Measure of 
Current Status
• 46 radical prostatectomy patients recruited 
to a stress management study
• Optimism, perceived stress management 
skills, and positive mood were correlated
• Relationship between optimism and positive 
mood might be mediated by perceived stress 
management skills.
Zakowski et al. (2003) • Cross-sectional study comparing men and 
women with cancer using the Social 
Constraints Scale, The Emotional 
Expressivity Scale, the Impact of Events Scale 
and the Profile of Mood States
• 41 men with PCA and 41 women with 
gynaecological cancer
• Men experienced greater distress in 
association with social constraints from their 
partners than did the women
• Men might have fewer outlets for emotional 
expression so constraints from partners 
might lead to greater distress.Page 6 of 14
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ratings. However, concordance was surprisingly poor.
In another study on men with metastatic PCA [38], but
with the advantage of a comparison group, patients were
randomised to one of three forms of HT or observation
and completed psychological measures at baseline and six
months later. As in Herr et al. [36] adjustment was similar
across all groups, despite impaired sexual functioning in
the hormone conditions. As part of their work, Green et
al. [39] obtained patients' verbal comments and found
substantial individual differences on such themes as
health beliefs and coping. A detailed analysis revealed
complex responses. Adjustment was worse in those with
physical comorbidity, suggesting the relevance of health
status in ascertaining adjustment associated with different
treatments. HT enhanced or decreased adjustment. The
position seems more intricate than conventional analyses
reveal, and raises the question of whether broad brush-
stroke patterns of psychological responses may mislead.
Another approach is to focus on a single psychological
aspect. Stone et al. [9] considered fatigue. After three
months of HT, fatigue had increased markedly but this
was not related to adjustment but to diminished muscle
function. Pirl et al. [40] selected depression in a heteroge-
nous PCA group and found its prevalence eight times the
national male rate. This was not associated with disease
progression or use of chemotherapy but to a prior history
of depression. Thus, history of disordered mood is a pos-
sible risk factor for depressive reactions in this group.
Comparing different treatments and psychological 
adjustment (see Table 7)
A typical study is by Lee et al. [41], in which patients with
localised PCA were treated with surgery, RT or BT. They
completed psychological measures before treatment and
at several points during the next year. Poor adjustment
was notable in the first month in the surgery and BT
groups but not the RT group. At 12 months the difference
had evaporated, with adjustment reverting to pre-therapy
levels. The authors posited that patients should be coun-
selled about differential treatment effects. We are less con-
vinced, given that these were remarkably similar after
three months. The non-randomised design, a serious lim-
itation, precludes setting guidelines.
Few teams have adopted a prospective design. In a RCT
comparing steroids and HT in men with metastatic PCA,
Fossa et al. [42] examined psychological effects over six
months. Patients on steroids were better off than their HT
counterparts. However, patients dropped out in both
groups because of deterioration in health and that the psy-
chological difference was observed particularly from the
third to the 12th week. We may also note the authors' cor-
ollary that steroids should be considered as a first choice
in hormone-resistant PCA but a brief comparison period
because of attrition suggests a more tentative conclusion.
The prospective study by da Silva [43] compared adjust-
ment after orchidectomy or HT over 12 months. However,
attrition proved such a problem that comparisons were
not feasible.
Table 4: Radical prostatectomy (RP) and psychological adjustment
Study Design Characteristics of the sample Major findings
Pietroff et al. (2001) • Retrospective, questionnaire – based 
inquiry, comparing those with (25%) and 
without PSA recurrence, an average 3 years 
post-surgery
• UCLA Prostate Cancer Index and the 
RAND 36-item Health Survey used
• 348 patients with localized disease • Small difference only on QOL between 
the 2 groups; generally, men well adjusted
• PSA-recurrence group, unexpectedly had 
higher scores on emotional well-being
Rosetti and Terrone (1996) • Retrospective inquiry (EORTC) 1 – 15 
years after RP
• 161 patients, of whom "over 80%" did not 
have metastases
• Minimal overall psychological impact
• 90% satisfied with surgery, and would opt 
to have it again
Heathcote et al. (1998) • Retrospective inquiry 1–6 years after 
surgery
• QOL measure constructed by authors
• 140 patients who had no evidence of 
recurrent or residual disease
• 90% satisfied with treatment, despite 
impotence in 40% of sample
Meyer et al. (2003) • Retrospective inquiry (ED – QOL)a 
median 7 years after surgery
• 89 patients with localized disease • Most patients felt adverse effects, 
including anger, guild and sadness associated 
with impotence.
• 75% of men had lowered self-esteem to 
some degree
Ficarra et al. (2000) • Retrospective inquiry an average 2 years 
after surgery; inclusion of control group of 
men who had RP for benign prostatic 
hyperplasia.
• General Health Questionnaire and the 
Hospital Depression and Anxiety Scale
• 30 patients with localized disease • Cancer patients had significantly higher 
levels of anxiety
• Depression levels similar in 2 groups; 
minimal in each group
Randorf-Klym and Colling (2003) • Retrospective inquiry 1–2 years following 
surgery
• QOL measure constructed by authors
• 88 patients • Perceived social support, self-esteem and 
health locus of control predicted post-
surgery QOL
• Suppression of anger and depression non-
predictorsPage 7 of 14
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treatment – either RT, RP or watchful waiting – at two and
12 months later in men with localized PCA. The three
groups showed improved adjustment over time but were
similar at all three points. The relevance of obtaining base-
line data is shown by the findings that QOL was similar to
that found in the community.
Other studies in this area are cross-sectional, retrospective
and lack baseline measures. The value of any findings is
thus diminished. Eton et al. [45], for instance, compared
adjustment to (non-randomised) RT, external beam RT
and BT in men with localised PCA. Given the limited
design, the three groups, not surprisingly, were similar in
role function, perception of health and emotional well-
being. A similar picture was found by Litwin et al. [46] in
their comparison of RP, RT, observation alone and con-
trol.
A comparison of adjustment in watchful waiting, HT, RT
and RP by Fossa et al. [47] (see their 2001 prospective
study above) was also cross-sectional and retrospective.
Despite physical morbidity in many patients, adjustment
was rated as good. As the authors surmised, men with PCA
seem to accept physical problems as the price for therapy
that might cure.
Lilleby et al. [48] measured, cross-sectionally, adjustment
of RT and RP a year following treatment. Desirable fea-
tures were sizable samples and a control group (a watch
and wait condition). Results were similar in both groups,
with less than one in 10 reporting poor adjustment.
In another adequately sized sample, this time of advanced
PCA patients, HT and orchidectomy were compared [49].
Adjustment improved after six months in the medical but
not surgical group. Given that this was not a RCT and that
follow-up was brief, proper comparisons are difficult, but
results suggest surgical HT may be less appropriate than
medical HT.
Two studies have examined the effects of treatments on
sexual functioning. Bokhour et al. [50] formed focus
groups of men who had undergone RT or BT for non-met-
astatic PCA sharing experiences of impotence. Although
this method serves as a fertile source of qualitative mate-
rial, pitfalls abound. Noteworthy here was sampling: men
were recruited from medical centres but how they were
selected is not stated, and only a third of 130 invitees par-
ticipated. Nevertheless, the approach highlights the value
of eliciting narratives, which may complement quantita-
tive data. Mixed methods of data collection warrant seri-
ous consideration.
The importance of prospective studies incorporating base-
line measures is vividly illustrated by Van Andel et al. [51].
They compared baseline profiles of men who received sur-
gery or external beam RT. The latter reported worse func-
tioning in physical, role, sexual and social domains. While
these differences might have been attributable to treat-
ment, it is critical to measure baseline psychological
Table 5: Radiotherapy (RT) and psychological adjustment
Study Design Characteristics of the sample Major findings
Caffo et al. (1996) • Retrospective "ad hoc" QOL questionnaire 
inquiry following RT
• 70 patients with localized PCA • Psychological adjustment and relational well-
being good
• Level of available information about PCA and 
RT correlate with adjustment
Joly et al. (1998) • Retrospective, controlled study of health-
related QOL (EORTC)
• 71 patients with localized disease treated 
with combined external beam RT and 
brachytherapy
• Treatment has no adverse effects
• Patients and controls similar on a range of 
measures but sexual and urinary symptoms 
more common in patients
Artebery et al. (1997) • Retrospective questionnaire (EORTC 
Prostate) study following brachytherapy
• 51 patients with localized PCA • Only a minority report psychological distress 
or disrupted social/family life
• Return rate to work – 93%
• 100% would recommend treatment to others
Monga et al. (1997) • Prospective
• Aim was to determine cause of fatigue in 
PCA patients receiving RT through 
questionnaire (Beck Depression Inventory and 
2 sleep scales) and measure of neuromuscular 
efficiency (NME)
• 13 patients with localized PCA • Significant but transient decline in NME, 
independent of psychological status; thus 
fatigue physically – based rather than 
influenced by depression
Monga et al. (1999) • Prospective evaluation, including fatigue, at 4 
points – before, during and after RT
• Same measures as in Monga et al. (1997)
• 36 patients with localised PCA • Fatigue scores significantly higher at end of 
treatment
• Not associated with psychological status eg. 
depression or with sleep.
• May be secondary to decline in 
neuromuscular efficiency and increased muscle 
fatigue
Greenberg et al. (1993) • Prospective study of fatigue and mood (Beck 
Depression Inventory) during treatment
• 15 patients with localised PCA • Fatigue increases with treatment, but 
independent of depression
• Fatigue associated with increased interleukin 
– 1 which could be a marker for fatigue 
associated with RTPage 8 of 14
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controlled.
The effects of psychological interventions on adjustment 
(see Additional file 1)
Given a diagnosis of life-threatening cancer like PCA, the
question arises as to whether interventions can be devised
to help patients (and possibly partners) with such seque-
lae as existential concerns, poor coping and psychiatric
morbidity. Considering the accomplishments in breast
cancer [52], the dearth of studies in PCA is striking; only a
few researchers have mounted an intervention to deal
with psychological needs.
Educational programs are the most common but limited
in what they set out to achieve. In an RCT, Helgesen et al.
[53] compared "treatment as usual" with a program in
which a trained nurse contacted the patient every six
months over three years (the patient could also initiate
contact) to explore general health and PCA-related diffi-
culties. There were no differences at baseline or follow-up.
The authors concluded that a nurse-based follow-up is
cost-effective and "safe", i.e. nothing serious is missed. Lit-
tle can be assumed about the psychological dimension,
given the focus on nurse as "doctor surrogate".
Another nurse-based study concentrated on preparing
patients for RT [54]. Routine nursing was offered as a con-
trolled condition, consisting of a brief "tutorial" on the
nature and side-effects of the treatment. The intervention
was delivered at four points: pre-RT, during the first and
last weeks of therapy, and one month following termina-
tion. Again, the goal was to inform the men about RT's
nature and side-effects, but in much more detail, and the
program also embraced psychological issues. The
researchers only found less disruption of customary life
activities in the intervention group compared with the
controls.
Hack et al. [55] audiotaped the patient-oncologist consul-
tation and compared its effects to a control group. Six
weeks later, patients who received audiotapes were better
able to recall information and were more satisfied with
the level of communication. This is not an elaborate initi-
ative but probably contributes to the doctor-patient alli-
ance. Whether psychological well-being is affected
remains unclear. A single tape might not exert much influ-
ence but, as part of a psycho-educational program, it
might help as a means to empower the patient.
Another way to enhance doctor-patient communication is
through printed information. Templeton and Coates [56]
conducted an RCT in which men with PCA receiving hor-
mone therapy were randomly assigned to receive an edu-
cation package or to a control condition. Significant
differences were found on knowledge about PCA and its
treatment and on QOL but the groups used similar coping
strategies. The absence of disease staging and only a one-
month follow-up are notable limitations.
Lepore and colleagues [57] examined group-based educa-
tion in men with localized PCA, comparing its effects with
a controlled condition and a more ambitious intervention
– an educational group plus discussion. The interventions
Table 6: Hormone therapy (HT) and psychological adjustment
Study Design Characteristics of the sample Major Findings
Herr et al. (2000) • Comparison of men treated with HT and 
men who defer such HT over 12 months
• EORTC – Prostate
• 144 patients with locally advanced PCA or 
PSA – relapse after surgery or radiotherapy
• Men on HT had significantly more fatigue, 
anergia and emotional distress then men who 
deferred HT
Herr et al. (1993) • Men choosing or postponing HT followed up 
for 6 months
• EORTC – Prostate
• 35 patients with metastatic PCA • Men on HT had more fatigue, psychological 
distress and sexual difficulties than those not 
on HT
da Silva et al. (1996) • QOL (constructed by authors) examined in 
men on HT followed up for 12 months, rated 
by both patients and their physicians
• 63 patients with newly diagnosed PCA • Poor correlation between the 2 sets of 
ratings
• Fatigue, and emotional and social functioning, 
did not improve with HT
Green (2002) • Study of QOL in PCA patient and control 
subjects over 6 months
• Measures included EORTC and COPE 
Coping Scale
• 65 patients with non-localised PCA 
randomized to one of 3 forms of HT
• 16 controls
• Emotional distress, self-efficacy and coping at 
baseline similar in treated and control groups
• HT patients worse or better in various 
domains of QOL suggesting complex links
• Overall, groups did not differ over time in 
psychological functioning
Stone et al. (2000) • Sample followed up for 3 months after HT 
with focus on fatigue
• Measures included EORTC, Hospital 
Depression and Anxiety Scale and 2 fatigue 
scales
• 58 patients, convenience sample, most with 
early stage disease
• Majority had significantly increased fatigue 
but not due to psychological factors (as was 
the case at baseline); rather due to diminished 
muscle function
Pirl et al. (2002) • Men receiving HT for an average 3.3 years 
surveyed for depression
• Measures included the Beck Depression and 
Fatigue Severity Scales
• 45 patients of whom 12 had metastatic 
disease.
• Major depression in 13%, 8 times the national 
rate in men
• Past history of depression a risk factor for 
depressive reactionPage 9 of 14
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"education plus discussion" patients were less bothered
by sexual difficulties and more likely to be in steady
employment than the other patients. The authors' specu-
lation that the opportunity to discuss personal problems
confers extra benefits is intuitively appealing.
Mishel et al. [58] examined the moderating effects of var-
iables such as race, education and number of sources of
information on two psycho-educational interventions for
localised PCA patients. Those with less education bene-
fited by increasing their knowledge; men with more
sources of information also did better. These results sup-
port implementing interventions that tailor content and
teaching methods to specific needs.
Only two teams [59,60] have tested more substantial
interventions, based on cognitive behaviour therapy
(CBT) strategies. In the former RCT [59], less than half the
patients were satisfied or reported any benefit after an
average 3.6 sessions. The study is replete with limitations:
only one in four invitees participated; data are presented
for treated patients but not for controls; treatment ranged
from one to 24 sessions, despite a set limit of eight; no
baseline assessments were obtained; and the sample was
heterogeneous (localised and metastatic disease).
The RCT by Petersson et al. [60] was substantially better in
design and execution. Treatment over eight weekly ses-
sions (and a booster) contained education, CBT and relax-
ation. Psychological distress three months after
commencement improved compared to controls but this
was confined to copers who actively sought information
in contrast to those who avoided doing so, identifying a
moderator of benefits. A snag is the range of therapeutic
components; the question remains as to which lead to
change.
Much has been written about support groups (SGs) in
cancer, particularly of the breast, but PCA does not feature
particularly. We have found only four papers, and none of
them illuminating. The differential gender attention
Table 7: Comparing different cancer treatments and psychological adjustment
Study Design Characteristics of the sample Major findings
Lee et al. (2001) • Prospective 12 months assessment of QOL 
(Functional Assessment of cancer therapy – 
Prostate) after surgery, radiotherapy or 
brachytherapy
• Patients with localized disease: 23 treated 
with surgery, 23 with radiotherapy and 44 with 
brachytherapy
• After one month, virtually no change in 
emotional well being in all 3 groups
• After 12 months, emotional well being similar 
to baseline in all 3 groups
Fossa et al. (2001) • Prospective assessment of QOL (EORTC) at 
6 weekly intervals until death
• 101 men treated with steroids, 100 with 
hormone therapy – all showing hormone-
resistant metastatic PCA
• Men on steroids have better role functioning 
and less fatigue, especially between weeks 3 
and 12.
• Because of attrition thereafter, comparisons 
between the two groups not possible
da Silva (1993) • QOL (EORTC – Prostate) assessed at 6 
months by urologists and patients
• 76 men with metastatic PCA – treated with 
orchidectomy or hormone therapy
• Because of feasibility problems, comparative 
analysis not possible
• Ratings by urologists correlate poorly with 
those of patients
Eton et al. (2001) • Cross-sectional assessment of QOL (UCLA 
Prostate Cancer Index) within 7 weeks of 
launch of treatment.
• Men with localised PCA; 156 treated 
surgically, 49 with radiotherapy, and 51 with 
brachytherapy
• 3 treatment groups similar in psychological 
aspects
• Support, self-efficacy and self-esteem predict 
better QOL
Litwin et al. • Observational study of PCA (Cancer 
Rehabilitation Evaluation System and Functional 
Assessment of Cancer Therapy – General) 
patients and age and ZIP-code matched 
controls
• 214 localized PCA patients
• 273 controls
• No differences in general QOL, including 
emotional well being, between surgery, 
radiotherapy and observation only sub-groups, 
or between PCA patients and controls
Fossa et al. (1997) • Cross-sectional, retrospective assessment of 
QOL (EORTC)
• 379 men with PCA of various stages: 57 
observed only, 112 received hormonal therapy, 
96 surgery
• Sexual impairment and fatigue common in 3 
treated groups but this does not have much 
effect on ratings of QOL
Lilleby et al. (1999) • Controlled, cross-sectional assessment of 
QOL (EORTC) one year after treatment
• 154 men with PCA of various stages received 
radiotherapy, 108 surgery; 38 control
• Emotional function similar in 3 groups
• Emotional function good or only slightly 
impaired in most patients
Cassileth et al. (1992) • Prospective assessment of QOL (Functional 
Living Index-Cancer) and mood at 3 and 6 
months follow-up
• 159 men with advanced PCA; 115 chose 
hormone therapy, 32 orchidectomy
• Mood improved at 3 months in both groups
• Improvement greater in hormone therapy 
than orchidectomy patients at 6 months
Bokhour et al. (2001) • Participation in focus group (7 groups); 
qualitative approach to QOL concerns
• Men treated 12–24 months previously
• 48 men with early PCA treated with surgery, 
radiotherapy or brachytherapy
• Most men had sexual difficulties in terms of 
sexual relationships, intimacy and sense of 
masculinity
• QOL – sexual effects – treatment type 
associations not mentioned
Van Andel et al. (2003) • QOL (EORTC) assessed pre-treatment only • 65 patients with localized disease treated 
surgically, 73 with radiotherapy
• Cognitive, but not emotional, function better 
in patients about to be treated surgically. Also 
especially in terms of sexual functioning and 
fatigue
Steginga et al. (2004) • Prospective study before one of three 
treatments and two and 12 months after 
treatment
• A range of psychological distress scales eg. 
Impact of Events Scale and Satisfaction with Life 
Scale
• 111 patients with localised disease – 56% 
treated surgically, 19% with RT and 25% with 
watchful waiting
• No differences found by medical treatment 
group in psychological adjustment at baseline 
or at follow-up.
• Overall QOL similar to community normsPage 10 of 14
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share their health concerns with others.
Krizek et al. [61] asked men with PCA about their experi-
ence of, and attitudes to, SGs. Only one in eight had
attended one or more meetings, but those who had, did so
an average 10 times, and valued sharing concerns. In-
depth enquiry of reasons for not attending might have
proved informative.
It would be worthwhile repeating such a study with a rep-
resentative sample and a more comprehensive form of
enquiry. Poole et al. [62] have accomplished this to a
degree. They administered questionnaires to PCA patients
recruited though SGs and radiotherapy/oncology clinics.
Not unexpectedly, both SG members and non-partici-
pants identified a spouse/partner as most helpful in pro-
viding emotional and practical support. The former relied
on SG members for information, the latter on doctors.
Possibly because of the prominent role of spouse/partner,
no differences emerged between the two groups regarding
coping and adjustment. SGs seem limited in their effects,
although they do need to be evaluated in a RCT.
Gregoire et al. [63] did not apply such a design in their
study of men (as well as "some" relatives) recruited to par-
ticipate in 10 weekly sessions led by a nurse and a psy-
chologist, which concentrated on information about PCA,
its effects and its treatments. Men who attended regularly
rated the experience highly since it helped them to cope
more effectively. The authors pointed to evidence for the
utility of SGs despite conceding the dubious representa-
tiveness of the sample and lack of baseline data.
Only one study has examined the value of an actual SG
intervention [64]. The researchers hypothesised that men
with PCA, facing the prospect of RT who received informa-
tion about the treatment, would cope more effectively
than controls. Taped material was given to men at four
points, each containing accounts by former patients of
their RT experience. One outcome variable differentiated
intervention from control groups – the former were far
less disrupted in their customary recreational activities
during and after treatment. The groups, however, were
similar in terms of negative mood, this probably attribut-
able to normal baseline levels. A similar study with more
emotionally distressed patients is clearly indicated.
Johnson [65] has extended this work by looking at the
role of optimism-pessimism. In a similar RCT, informa-
tion exerted a positive effect in pessimistic patients. Again,
intervention led to less disruption of recreational activi-
ties, this time in both optimistic and pessimistic men.
An interesting variation of the SG emerges from the pilot
work of Weber et al. [66] who recruited 10 long-term
(three plus years) PCA "survivors" of RP to serve as part-
ners over eight weekly sessions to men who had under-
gone surgery for PCA. The latter were randomised to this
intervention or to a control condition. Self-efficacy
increased in the peer-supported men but not in the con-
trols but benefit in terms of depression was limited.
Although the small sample precluded adequate statistical
treatment the self-help rationale is sound and may suit
men who are hesitant about participating in a group.
In arguing the need for an RCT to test the efficacy of SGs,
we are not suggesting neglect of other methods. Qualita-
tive research, for instance, enables us to learn about group
therapeutic factors involved. A good example is
Arrington's [67] participant observation. Interested in
how the men dealt with sexuality, he observed a dispro-
portionate emphasis on performance but was cognisant of
three limitations: excluding the perspective of spouses/
partners, thereby neglecting relational dynamics; using a
restricted sample of men from a retirement community;
and the fluctuating nature of group membership. Not-
withstanding, the approach complements traditional
methods and further qualitatively-based research is
worthwhile.
The quality of research on psychological interventions
varies. Considerably more sophisticated therapies are
needed through which psychological distress can be
addressed. While education and problem solving have a
place, RCTs directed to such features as depression, anxi-
ety, marital strain and poor coping are needed.
Discussion
Although this review reveals many gaps in knowledge,
embryonic patterns are emerging. Cross-sectional studies
comparing men with PCA and controls suggest few differ-
ences in levels of psychological distress. But we must
appreciate that PCA patients constitute a heterogeneous
group and that adjustment is better in those with localised
disease compared to those with advanced forms.
Longitudinal studies do not suggest that adjustment wors-
ens over time. However, early signs of distress, particularly
depression and anxiety, indicate a poorer psychological
prognosis. Coping that involves interpersonal awareness
and expression of emotions is linked to better adjustment.
By contrast, a sense of helplessness correlates with low
self-esteem and depression.
Implications for clinicians
Clinicians would be advantaged if able to detect distress in
their patient and in the couple, as well as to identify those
at risk, and in knowing about programs that alleviate psy-Page 11 of 14
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lated thus far. We can only rely on low-level evidence such
as that emerging from observational studies.
Men with PCA do not appear to experience marked
impairment of adjustment; the rate is much less than that
of women with breast cancer. As is well established in
men's health research, low rates of morbidity may reflect
a belief that admitting to personal difficulties and the
need for help is a "sign of weakness" [68]. Moreover, ques-
tionnaire-based designs may fail to penetrate these
"avoidant" responses.
An alternative to the questionnaire is the focus group.
Qualitative data may be as valuable as quantitative data.
Thus, in the study by Bokhour [50], participants felt able
to talk about sexual impotence and related concerns. The
typical limitation is the poor generalization of findings.
Given the low rate of psychological morbidity, the clini-
cian's ability to identify predictors would at least enable
them to monitor "at risk patients". At this stage, however,
statements about predictors cannot be made. Longitudi-
nal studies with adequate methodology are essential to
address this question and these are rare.
We had anticipated differential effects on adjustment of
the medical treatments offered to men with PCA but out-
comes tend to be uniform. We should remember, how-
ever, that they tend to start with low levels of distress. A
corollary is the role of psychological outcomes in deci-
sion-making about treatment. If it were the case, for
instance, that a specific treatment affected mood
adversely, clinicians could point this out in the consent
process.
One study alerts us to the dangers of possible artefacts in
calculating mean scores for presumed homogeneous pop-
ulations. Green [38] found a mixed pattern when examin-
ing the psychological effects of hormone therapy – one
subgroup improved, another deteriorated. Moderating
factors are elusive but their likely relevance makes it
imperative to identify them.
Even if we could identify those at risk, the literature does
not guide the clinician to interventions of proven value.
This aspect is the most scanty of all those researched. Edu-
cational strategies and support groups have negligible
influence. The role of psychotherapy is unclear, since trials
are rare, and limited methodologically. For the moment,
the clinician must resort to ideographic appraisal regard-
ing the sort of help a patient requires.
Implications for researchers
The implications that follow mirror the limitations noted
throughout the review, namely: sampling, design, con-
trols, outcome measures and statistical methods.
The most striking feature is the need for studies of ade-
quate standard. Consider sampling: larger, more repre-
sentative and well-described samples are required, e.g.,
age, socio-economic status, ethnicity, education, stage of
cancer and treatment received. A key strategy is multi-site
recruitment. Even then, a sample with enough power
takes time to generate; selection criteria guarantee that.
Aspects of design also need attention. Cross-sectional
"snapshots" are of limited value in that they fail to tell us
how long symptoms persist and who is vulnerable to
enduring maladjustment. A snapshot at the point of diag-
nosis is bound to be influenced by reactions on learning
one has a life-threatening illness. Similarly, assessment
following one or another treatment will be affected by the
nature of that treatment. Only prospective, longitudinal,
repeated measures designs can illuminate the patient's
journey and identify risk factors.
Control groups are crucial even though they present diffi-
culties, especially for an observational study. In any treat-
ment study, a control condition is essential if results are to
be taken seriously. Recruitment might be less thorny than
for prevalence studies; the ethical dilemma of not provid-
ing treatment is not insurmountable since there is no cur-
rent psychological standard intervention for men with
PCA.
A close examination of psychometric issues is beyond the
scope of this paper but valid and reliable measures to
describe the psychological features of PCA patients and to
use as outcome criteria are required. The variegated and,
in some cases, home-baked measures encountered has
precluded confident interpretation of the results emerging
from their use. Researchers need to concentrate on well-
established instruments, like the Beck Depression and the
Brief Symptom Inventories, and evaluate them in a con-
certed way.
Qualitative work is a valuable complement to quantitative
research. There is scope to encompass thematic analyses
in future research, especially with the advent of sophisti-
cated software to examine patients' narratives.
Statistical methods have improved substantially in recent
years and need to be applied in future work. Consider two
of many possible illustrations: sampling and differential
outcome. In allocating men with PCA to different arms of
a RCT, it will be vital to do so with rigor, including the
need for stratification. We will need to examine a range ofPage 12 of 14
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cal groups of patients, e.g., on a spectrum of severity of
psychological distress.
Conclusion
Psychological adjustment to PCA has attracted growing
interest of investigators but the yield over the past decade
has, in contrast to the picture in breast cancer, been mea-
gre, both in terms of the number of studies carried out and
their methodological rigour. If future research is to prove
more useful, the bar will need to be raised. Fortunately,
several leads have emerged; the time has arrived to make
the most of them.
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